期刊文献+

雌激素、促性腺激素与大鼠成骨细胞雌激素受体β的表达 被引量:1

Expression of estrin,gonadotropic hormone and estrin receptor beta of osteoblasts in rats
暂未订购
导出
摘要 目的:观察不同剂量雌激素,卵泡雌激素及黄体生成素对大鼠成骨细胞雌激素受体β表达的影响。方法:实验于2004-02/08在哈尔滨医科大学第二临床医学院科研中心完成。①取三四个月龄雌性Wistar大鼠28只用于大鼠成骨细胞体外培养。采用二次酶消化、反复贴壁法分离纯化培养大鼠成骨细胞。观察其形态、改良钙钴法碱性磷酸酶染色,培养上清碱性磷酸酶、骨钙素测定来鉴定成骨细胞。②取2代培养的成骨细胞用无血清培养基培养24h,分为10组:对照组,1×10-10,1×10-8,1×10-6mol/L17β-雌二醇组,10,100,1000U/L黄体生成素组,1×10-7,1×10-6,1×10-5g/L卵泡刺激素组。每组3个孔。对照组加入基础培养基,其他各组分别加入相应终浓度药物,培养24~48h。大鼠成骨细胞雌激素受体表达阳性细胞数检测应用免疫组织化学法测定,以细胞浆有棕黄色颗粒沉积为阳性。成骨细胞雌激素受体β表达检测应用半定量免疫印渍酶促底物染色法以及化学发光法,以A值越高,说明雌激素受体β表达越多。结果:①成骨细胞形态及特征性鉴定:成骨细胞随培养时间的延长,细胞呈指数增长,分泌碱性磷酸酶和骨钙素,碱性磷酸酶染色阳性率为90%,表现出旺盛的分泌功能。②成骨细胞雌激素受体表达阳性细胞数检测结果:不同剂量卵泡刺激素组和黄体生成素组对雌激素受体表达无明显影响;雌激素1×10-8mol/L组和1×10-6mol/L组显著高于对照组[(90.95±5.89),(95.12±6.17),(81.44±5.37)个数/100个细胞,t=2.95,P<0.05;t=3.50,P<0.01]。③成骨细胞雌激素受体β表达结果:不同剂量卵泡刺激素及黄体生成素对雌激素受体β的表达无明显影响;随雌激素浓度的增加成骨细胞雌激素受体β表达呈上升趋势。结论:雌激素能促进成骨细胞雌激素受体β的表达,且表现出剂量依赖性。而黄体生成素、卵泡刺激素对雌激素受体β表达无直接影响。 AIM: To observe the effects of estrogen, follicle estrin and luteinizing hormone at different dosage on the expression of estrin receptor β of osteoblasts in rats. METHODS: The experiment was done in Science Research Center of Second Clinical Medical College of Harbin Medical University from February to August 2004. ① Twenty-eight female Wistar rats aged three or four months were selected. The osteoblasts were isolated and cultured in vitro and pured from female Wistar rats by twice enzyme digestion and repeated strapping. Osteoblasts characteristics were identified by Gomori method staining, measuring alkaline phosphatase. Osteoblasts were detected by supernatant phosphatase and osteocalcin. ② The second generation of cells was cultured in serum-free medium for 24 hours and divided into 10 groups. Control group, 1×10-10,1×10-8,1×10-6 mol/L17β; Aquadiol group, 10,100,1 000U/L; Luteininzing hormone group, 1×10-7,1×10-6,1×10-5 g/L and follicle stimulating hormone group, with three apertures in each group. Basic medium was added into control group, and corresponding concentration drug was added into the other groups cultured for 24 to 48 hours. The number of positive cells of estrin receptor of osteoblast in rats was detected by immunohistochemistry method. It was positive with deposition of buffy granule in cell plasm. Expression of estrin receptor β of osteoblast was detected with semi-quantu immunoblotting enzyme substrate staining method and chemiluminescence method. The higher the A result was, the more the expression of estrin receptor β. RESULTS: ① Evaluation of form and character of osteoblast: Osteoblasts performed exponential growth as the time of culture long and excreting alkaline phosphatase and osteocalcin, positive rate of alkaline phosphatase staining was 90%, which expressed productive excretion function. ② Detection result of positive cells of estrin receptor: There were no significant effects on the expression of estrin receptor in follicle stimulating hormone group and luteinizing hormone group at different dosage. The results of estrin group at 1×10-8 mol/L and at 1×10-6 mol/L were significantly higher than that in control group [(90.95±5.89),(95.12±6.17),(81.44±5.37)per 100 cells,(t=2.95, P < 0.05;t=3.50, P < 0.01)]. ③ The expression results of estrin receptor β of osteoblast: There were no significant effects of follicle stimulating hormone and luteinizing hormone on the expression of estrin receptor β at different dosage. As the increase of estrin concentration, the expression of estrin receptor β of osteoblast showed increasing trend. CONCLUSION: Estrin can accelerate the expression of estrin receptor β of osteoblast and show the dosage-dependence. Luteinizing hormone and follicle stimulating hormone has no direct effect on the expression of estrin receptor β.
出处 《中国临床康复》 CAS CSCD 北大核心 2005年第23期172-174,i004,共4页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献8

  • 1周振雷,侯加法.雌激素对骨代谢的调节作用[J].中国临床康复,2004,8(14):2714-2715. 被引量:12
  • 2J.萨姆布鲁克 E.F.弗里奇 T.蔓尼蒂斯.分子克隆实验指南[M].2版[M].北京:科学出版社,1996.888-902.
  • 3Komm BS, Terpening CM, Benz DJ, et al. Estrogen binding, receptor mRNA,and biologic response in osteoblast-like osteosarcoma cells. Science 1988 ;241 (4861):81-4
  • 4Eriksen EF. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241(4861):84-6
  • 5Sutherland MK,Hui DU,Rao LG et al. Immunohistochemical localization of the estrogen receptor in human osteoblastic SaOS-2 cells: association of receptor levels with alkaline phosphatase activity.Bone 1996;18(4):361-9
  • 6Vladusic EA, Homby AE, Guerra Vladusic FK,et al. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.Oncol Rep 2000;7(1):157-67
  • 7Ebeling PR,Atley LM,Gnthrie JR, et al. Bone turn over markers and bone density across the menopausal transition. Clin Endocrinol Metab 1996;81(9):3366-71
  • 8林东平,吴万龄,杨裕国,郭郁郁,施丹.绝经后妇女不同骨量、骨代谢生化指标及其他相关因素的初步研究[J].上海医学,2000,23(2):102-104. 被引量:4

二级参考文献28

  • 1Huang Q, Wang QH, Zhang LP, et al. Relationship between bone mineral density and polymorphism of the estrogen receptor gene in healthy postmenopausal women in China. Chinese Medical Journal (English Edition) 1999; 112(9):832-5
  • 2Tou L, Quibria N, Alexander JM. Regulation of human cbfal gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs) . Mol Cell Endocrinol 2001 ;183(1-2):71-9
  • 3Tsutsumimoto T, Kawasaki S, Ebara S, et al. TNF-alpha and IL-lbeta suppress N-cadherin expression in MC3T3-El cells. J Bone Miner Res 1999; 14(10):1751-60
  • 4Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss mediastion by interleukin-6. Science 1992 ;257 (5066):88-91
  • 5Cheng MZ, Zaman G, Bawlinson SCF, et al. Mechanical strain stimulates ROS cell proliferation through IGF-Ⅱ and estrogen through IGF-I. J Bone Miner Res 1999; 14(10):1742-50
  • 6Hunziker J, Wronski TJ, Miller SC. Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone. J Dent Res 2000; 79 (6):1431-8
  • 7Zhou H, Shen V, Dempster DW, et al. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 2001; 16 (7):1300-7
  • 8Arjmandi BH. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll of Nutr 2001; 20(5-Supp1):398S-402S:discusion417s-20s
  • 9Picherit C, Coxam V, Bennetau-Pelissero C, et al. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 2000; 130(7):1675-81
  • 10Sugimoto E, Yamaguchi M. Stimulatory effect of Daidzein in osteoblastic MC3T3-El cells. Biochem Pharmacol 2000;59(5):471-5

共引文献15

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部